Hydrex

Active Ingredient & Mechanism of Action

• Active Ingredient: Hydrochlorothiazide.
• Mechanism: Hydrex acts directly on the distal convoluted tubules of the kidneys:
  1. Inhibition of Electrolyte Reabsorption: It inhibits the $\text{Na}^+/\text{Cl}^-$ co-transporter system, preventing the reabsorption of sodium and chloride ions.
  2. Increased Diuresis: By retaining sodium and water in the renal tubules, it increases urine production, facilitating the elimination of excess salt and fluid from the bloodstream.
  3. Blood Pressure Reduction: Removing excess intravascular volume decreases overall blood volume and cardiac workload. Over time, it also promotes direct relaxation of peripheral blood vessels, further lowering systemic blood pressure.

Available Strengths & Dosage Forms

• Hydrex 25 mg Tablets: Standard dosage strength containing 25 mg of hydrochlorothiazide per tablet.
• Hydrex-Semi (12.5 mg): A lower-strength formulation used when lower initial doses or fine-tuned combination therapies are required.

Clinical Indications

• Essential Hypertension: Used as monotherapy or in combination with other antihypertensive drugs (such as ACE inhibitors, ARBs, or calcium channel blockers) to control blood pressure and reduce the risk of stroke, myocardial infarction, and kidney failure.
• Edema (Fluid Retention): Management of fluid buildup associated with congestive heart failure, hepatic cirrhosis, and chronic renal disease, or edema induced by corticosteroid and estrogen therapies.
• Off-Label / Secondary Uses: Used in the management of nephrogenic diabetes insipidus and to reduce hypercalciuria (excess calcium in urine) to prevent recurrent calcium-based kidney stones.

Key Pharmacokinetics

• Onset of Action: Diuretic effects begin within 2 hours after oral ingestion, reaching peak effect at around 4 hours.
• Duration of Action: Sustained therapeutic action lasts approximately 6 to 12 hours.
• Elimination: Hydrochlorothiazide is not extensively metabolized by the liver; it is excreted mostly unchanged through the kidneys into the urine.

Administration Guidelines

• Usage: Administered orally once daily (or as prescribed), taken with water.
• Timing: It is best taken in the morning (with or after breakfast) to prevent nighttime urination from disrupting sleep.

Safety Profile & Considerations

• Common Side Effects: Frequent urination, lightheadedness, dizziness (especially when standing up), mild headache, loss of appetite, and fatigue.
• Electrolyte & Metabolic Disturbances:
  • Hypokalemia (Low Potassium): Increased potassium excretion can cause muscle weakness, cramps, or cardiac arrhythmias.
  • Hyponatremia & Hypomagnesemia: Risk of low sodium and magnesium levels.
  • Hyperuricemia: May elevate blood uric acid levels, potentially triggering gout attacks in susceptible patients.
  • Hyperglycemia: May impair glucose tolerance in diabetic patients.
• Contraindications:
  • Anuria (inability to produce urine).
  • Severe renal or hepatic failure.
  • Known hypersensitivity to hydrochlorothiazide or other sulfonamide-derived (“sulfa”) drugs.
• Key Interactions:
  • Digitalis / Digoxin: Hypokalemia induced by Hydrex increases the risk of digitalis toxicity.
  • NSAIDs: Non-steroidal anti-inflammatory drugs (e.g., ibuprofen) can diminish the antihypertensive and diuretic efficacy of Hydrex and elevate the risk of renal toxicity.
  • Lithium: Thiazides decrease the renal excretion of lithium, significantly increasing the risk of lithium toxicity.
  • Other Antihypertensives: Additive hypotensive effects when combined with other blood pressure medications.

Note: Hydrex is a prescription-only medication. Treatment, dosage adjustments, and monitoring of renal function and blood electrolytes must be managed under the supervision of a licensed healthcare professional.